Your browser doesn't support javascript.
loading
Opportunities to accelerate extracellular vesicle research with cell-free synthetic biology.
Kelwick, Richard J R; Webb, Alexander J; Heliot, Amelie; Segura, Clara Tresserras; Freemont, Paul S.
Afiliación
  • Kelwick RJR; Section of Structural and Synthetic Biology Department of Infectious Disease Imperial College London London UK.
  • Webb AJ; Section of Structural and Synthetic Biology Department of Infectious Disease Imperial College London London UK.
  • Heliot A; Section of Structural and Synthetic Biology Department of Infectious Disease Imperial College London London UK.
  • Segura CT; Department of Metabolism Digestion and Reproduction, Imperial College London London UK.
  • Freemont PS; Section of Structural and Synthetic Biology Department of Infectious Disease Imperial College London London UK.
J Extracell Biol ; 2(5): e90, 2023 May.
Article en En | MEDLINE | ID: mdl-38938277
ABSTRACT
Extracellular vesicles (EVs) are lipid-membrane nanoparticles that are shed or secreted by many different cell types. The EV research community has rapidly expanded in recent years and is leading efforts to deepen our understanding of EV biological functions in human physiology and pathology. These insights are also providing a foundation on which future EV-based diagnostics and therapeutics are poised to positively impact human health. However, current limitations in our understanding of EV heterogeneity, cargo loading mechanisms and the nascent development of EV metrology are all areas that have been identified as important scientific challenges. The field of synthetic biology is also contending with the challenge of understanding biological complexity as it seeks to combine multidisciplinary scientific knowledge with engineering principles, to build useful and robust biotechnologies in a responsible manner. Within this context, cell-free systems have emerged as a powerful suite of in vitro biotechnologies that can be employed to interrogate fundamental biological mechanisms, including the study of aspects of EV biogenesis, or to act as a platform technology for medical biosensors and therapeutic biomanufacturing. Cell-free gene expression (CFE) systems also enable in vitro protein production, including membrane proteins, and could conceivably be exploited to rationally engineer, or manufacture, EVs loaded with bespoke molecular cargoes for use in foundational or translational EV research. Our pilot data herein, also demonstrates the feasibility of cell-free EV engineering. In this perspective, we discuss the opportunities and challenges for accelerating EV research and healthcare applications with cell-free synthetic biology.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Extracell Biol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Extracell Biol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos